Research
Hormonal
The FDA authorizes the use of injectable semaglutide for the treatment of obesity.
Practitioners can consider semaglutide as an approved treatment option for obesity in the U.S.
StrongSupportsmedium confidence
A Food and Drug Adminstration (FDA), que regula os medicamentos nos Estados Unidos, autoriza o uso de semaglutida injetável no tratamento da obesidade.
Why this rating
The claim is based on regulatory approval, which is a strong form of evidence.
Source
Uso de semaglutina no tratamento da obesidade / Use of semagglutin in the treatment of obesity
Ana Marcela Teodoro Timo et al. · Brazilian Journal of Health Review · 2022
otherCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →